ERCC2 and xeroderma pigmentosum: Mutation in three of the XP genes, XPB, XPD and XPG can give rise to combined phenotypes of XP and CS (XP-CS) with neurological dysfunctions reminiscent of CS combined with the typical skin abnormalities of XP, including increased cancer incidence [14,15].